No matches

Type 2 Inflammation

ADVENT at ERS 2026

Join Sanofi and Regeneron for four educational symposia on asthma, COPD, and the unified airway.

Monica Kraft +11 more

Remind me

5 - 9Sept2026

Begins in

19days

8hours

Location

Fira Gran Via

Fira Gran Via (Halls 1 to 3), Carrer de les Ciències, s/n, Hospitalet de Llobregat, 08908 Barcelona.

Symposium Details

September 6

Breaking Silos Between Asthma and CRSwNP: Loss of Smell as a Marker of Unified Airway Disease

Join global experts in pulmonology, allergology, and rhinology as they discuss the role of type 2 inflammation across the unified airway, the amplified burden, and the difficulty controlling inflammation when asthma and CRSwNP coexist. Explore the available clinical data supporting the impact of current therapies on olfaction, lung function, and disease control.

September 7

Clinical Insights into Advanced Biologic Therapy For Type 2 COPD

Join global experts for an educational symposium on the evolving need for patient phenotyping and timely intervention, the utility of eosinophils and imaging-based biomarkers in identifying treatable traits in COPD. Explore the available clinical data supporting the impact of current therapies across patients with type 2 inflammation.

September 7

More than Exacerbations: Rethinking What Else Matters in COPD Management

Join global experts for an interactive discussion that builds on insights from ADVENT’s earlier symposium. Through a fireside chat format, our panel will explore key considerations in COPD management beyond exacerbations, including the impact of lung function decline and mucus plugging on disease burden and progression, and discuss the clinical rationale for earlier intervention.

September 8

Distal Airways, Central Role? Clinical Insights Into Type 2 Severe Asthma

Join global experts for a medical symposium on the importance of assessing small airway disease in asthma and the role of type 2 inflammation on airway remodeling. Explore the available clinical data supporting the effect of current therapies on peripheral airways in asthma.

Location

Fira Gran Via

Fira Gran Via (Halls 1 to 3), Carrer de les Ciències, s/n, Hospitalet de Llobregat, 08908 Barcelona.

Speakers

Pulmonology

Monica Kraft

Murray M. Rosenberg Professor of Medicine and System Chair for the Department of Medicine | Mount Sinai Health, New York, United States

Pulmonology

MD, PhD

Roland Buhl

Professor of Medicine | Johannes Gutenberg University of Mainz, Germany | Head of the Pulmonary Department | Mainz University Hospital, Germany

Rhinology

MD, PhD

Joaquim Mullol

Director of the Rhinology Unit & Smell Clinic, Department of Otorhinolaryngology | Hospital Clinic, Barcelona, Spain; Professor of Research and Head of the Laboratory of Clinical and Experimental Respiratory Immunoallergy | August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain | Head of Research Group at Biomedical Research Network on Respiratory Diseases (CIBERES) | Carlos III Institute of Health, Barcelona, Spain

Pulmonology

MD, PhD

Celeste Porsbjerg

Professor of Severe Asthma, Bispebjerg Hospital Copenhagen, Denmark

Pulmonology

MD, MSc

Simon Couillard

Professor Couillard is a respirologist and the Québec Lung Association Chair of Respiratory Research at the Université de Sherbrooke, Canada. He leads a team investigating ways to use biomarkers to predict and prevent asthma attacks and improve asthma management.

Pulmonology

Surya Bhatt

Dr. Surya Bhatt serves as the Medical Director of the UAB Pulmonary Function and Exercise Physiology Lab, a state-of-the-art lab for pulmonary physiology testing, and as Medical Director of Pulmonary Rehabilitatio

Pulmonology

MD, PhD, FERS

Klaus Rabe

Professor of Pulmonary Medicine | University of Kiel; Director of the Department of Pneumology | LungClinic Grosshansdorf, Kiel, Germany

Rhinology

MD, MS, FAAAAI, FACAAI

Giselle Mosnaim

Giselle Mosnaim is a board-certified allergist and immunologist at Endeavor Health and Clinical Assistant Professor at the University of Chicago Pritzker School of Medicine. An internationally recognized expert in asthma and allergic diseases, her clinical and research interests focus on severe and uncontrolled asthma, digital health, and improving patient outcomes through innovative, evidence-based care.

Pulmonology

Frederik Trinkmann

Frederik Trinkmann, MD, is an associate professor at Heidelberg University in Heidelberg, Germany. Additionally, he is an executive senior physician in the department of pulmonology and respiratory medicine and director of the Asthma Outpatient Clinic at the Thoraxklinik within Heidelberg University Hospital. Additionally, Professor Trinkmann serves as a research associate in the department of biomedical informatics in the Center for Preventative Medicine and Digital Health Baden-Württemberg at the University Medical Center Mannheim in Mannheim, Germany.

Pulmonology

MD, PhD

Arnaud Bourdin

Arnaud Bourdin, MD, PhD, is head of pulmonology and a professor of respiratory medicine at the University of Montpellier’s Arnaud de Villeneuve Hospital in Montpellier, France. He is an associate dean of the University of Montpellier’s faculty of medicine. He also acts as the leader of the Respiratory Diseases and the Environment research team at the Physiology & Experimental Medicine of the Heart and Muscles Laboratory. Professor Bourdin earned both his medical degree and PhD from the University of Montpellier, which he followed with a fellowship at Monash University in Melbourne, Australia.

Pulmonology

MD, MS

Fernando Martinez

Fernando J. Martinez, MD, MS, is a professor in the division of pulmonary medicine and interim chair of the department of medicine at the University of Massachusetts Chan Medical School in Worchester, Massachusetts. There, Dr Martinez also holds the positions of Joseph D. Early chair in biomedical research, vice chair of clinical and translational research, executive director of the department of medicine’s Clinical Research Core, and academic chief of the division of pulmonary, allergy, and critical care medicine.

Pulmonology

MD, PhD

Maarten van den Berge

Maarten van den Berge, MD PhD, is a pulmonologist and professor at the University Medical Center Groningen, The Netherlands.

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: Saudi ArabiaChange country/region